Abbott Laboratories (NYSE: ABT) started the day on July 13, 2021, with a price decrease of -0.13% at $118.65. During the day, the stock rose to $119.26 and sunk to $118.11 before settling in for the price of $118.81 at the close. Taking a more long-term approach, ABT posted a 52-week range of $91.71-$128.54.The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 11.10%. Meanwhile, its Annual Earning per share during the time was 7.80%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 24.50%. This publicly-traded company’s shares outstanding now amounts to $1.78 billion, simultaneously with a float of $1.76 billion. The organization now has a market capitalization sitting at $209.97 billion. At the time of writing, stock’s 50-day Moving Average stood at $114.81, while the 200-day Moving Average is $114.50.
While finding the extent of efficiency of the company that is accounted for 109000 employees. It has generated 317,505 per worker during the last fiscal year. Meanwhile, its income per employee was 40,817. The stock had 5.85 Receivables turnover and 0.49 Total Asset turnover. For the Profitability, stocks gross margin was +50.21, operating margin was +15.29 and Pretax Margin of +14.36.
Abbott Laboratories (ABT) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Medical Devices Industry. Abbott Laboratories’s current insider ownership accounts for 0.70%, in contrast to 75.70% institutional ownership. According to the most recent insider trade that took place on Apr 30, this organization’s SENIOR VICE PRESIDENT sold 94,576 shares at the rate of 119.90, making the entire transaction reach 11,339,739 in total value, affecting insider ownership by 59,783. Preceding that transaction, on Apr 27, Company’s SENIOR VICE PRESIDENT sold 9,439 for 122.00, making the whole transaction’s value amount to 1,151,558. This particular insider is now the holder of 51,083 in total.
Abbott Laboratories (ABT) Earnings and Revenue Records
This company achieved a net margin of +12.86 while generating a return on equity of 13.93.
Abbott Laboratories’s EPS increase for this current 12-month fiscal period is 24.50% and is forecasted to reach 4.63 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 12.84% through the next 5 years, which can be compared against the 7.80% growth it accomplished over the previous five years trading on the market.
Abbott Laboratories (NYSE: ABT) Trading Performance Indicators
Let’s observe the current performance indicators for Abbott Laboratories (ABT). It’s Quick Ratio in the last reported quarter now stands at 1.30. The Stock has managed to achieve an average true range (ATR) of 1.71. Alongside those numbers, its PE Ratio stands at $36.95, and its Beta score is 0.65. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 5.62. Similarly, its price to free cash flow for trailing twelve months is now 42.97.
In the same vein, ABT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 3.21, a figure that is expected to reach 1.02 in the next quarter, and analysts are predicting that it will be 4.63 at the market close of one year from today.
Technical Analysis of Abbott Laboratories (ABT)
If we take a close look at the recent performances of Abbott Laboratories (NYSE: ABT), its last 5-days Average volume was 4.02 million that shows plunge from its year to date volume of 5.75 million. During the previous 9 days, stock’s Stochastic %D was recorded 77.60% While, its Average True Range was 1.68.
Raw Stochastic average of Abbott Laboratories (ABT) in the period of the previous 100 days is set at 66.25%, which indicates a major fall in contrast to 83.51% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 14.29% that was lower than 23.91% volatility it exhibited in the past 100-days period.